{
    "code": "52026942",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026942",
    "time": "2023-10-26 19:39:07",
    "許可證字號": "衛部藥輸字第026942號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/18",
    "發證\/登錄日期": "105\/11\/18",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202694202",
    "中文品名": "善妥達持續性藥效肌肉注射懸浮劑",
    "英文品名": "Invega Trinza Prolonged-Release Suspension for Injection",
    "適應症": "INVEGA TRINZA (paliperidone palmitate)是一種3個月型注射劑，用於已使用INVEGA\r\nSUSTENNA® (1個月型paliperidone palmitate 持續性藥效注射用懸浮液)充分治療至少4 個月後之思覺失調症患者。",
    "劑型": "27B持續性藥效肌肉注射用懸浮液",
    "包裝": "0.875毫升、1.315毫升、1.75毫升及2.625毫升注射針筒裝附2支安全針頭",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PALIPERIDONE PALMITATE",
    "限制項目": "02輸　入 26監視期滿新藥",
    "申請商名稱": "嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "TURNHOUTSEWEG 30, 2340, BEERSE, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816100710",
            "成分名稱": "PALIPERIDONE PALMITATE",
            "含量描述": "(equivalent to 200 mg\/ml paliperidone)",
            "含量": "312.0000000000",
            "單位": "MG\/ML"
        }
    ],
    "仿單外盒": [
        {
            "title": "163011_5. 善妥達持續性藥效肌肉注射懸浮劑_仿單v2101_20211022-110-11-11.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=005&Type=9"
        },
        {
            "title": "Trinza 525mg photo_20201103-109-11-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=004&Type=8"
        },
        {
            "title": "Trinza 350mg photo_20201103-109-11-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=003&Type=8"
        },
        {
            "title": "525外觀-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=002&Type=8"
        },
        {
            "title": "350外觀-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026942&Seq=001&Type=8"
        }
    ]
}